Welcoming the European Commission’s discussion paper on how to treat botanical health claims within the legislation, EHPM said that Option 2 – to address it through a review of the legislation – is the most logical way forward, given that the assessment methodology for these health claims should, because of the specificities of botanicals, rely on traditional use.
